Trials / Completed
CompletedNCT01333436
A Study to Evaluate Fasting/Postprandial Serum Apolipoprotein B-48 (ApoB-48) Levels in Diabetic Participants With Normal to Moderately High Low Density Lipoprotein-C (LDL-C) Levels (MK-0653A-259 AM1)
A Multicenter, Cross-sectional Study to Evaluate Plasma ApoB-48 Concentration Among Korean Diabetic Patients (With Normal to Moderately High LDL-C Levels)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 93 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study will evaluate whether fasting/postprandial serum ApoB-48 levels are increased in diabetic participants compared to nondiabetic participants with the same range of serum LDL-C levels, and whether ApoB-48 levels can be used, along with LDL-C levels, to identify potential cardiovascular disease risk.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Test Meal | During Visit 2, a test meal will be supplied by the Sponsor of approximately 944 kcal (57% fat, 31% carbohydrate, and 12% protein), and postprandial blood draws will be done at 1, 2, 3, 4, and 6 hours after the meal. |
Timeline
- Start date
- 2011-07-20
- Primary completion
- 2012-05-12
- Completion
- 2012-05-12
- First posted
- 2011-04-12
- Last updated
- 2024-05-13
- Results posted
- 2013-04-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01333436. Inclusion in this directory is not an endorsement.